Bioasis Technologies Stock Profit Margin
BIOAF Stock | USD 0.0001 0.00 0.00% |
biOasis Technologies fundamentals help investors to digest information that contributes to BiOasis Technologies' financial success or failures. It also enables traders to predict the movement of BiOasis Pink Sheet. The fundamental analysis module provides a way to measure BiOasis Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BiOasis Technologies pink sheet.
BiOasis |
biOasis Technologies Company Profit Margin Analysis
BiOasis Technologies' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, biOasis Technologies has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
BiOasis Fundamentals
Return On Asset | -0.81 | |||
Operating Margin | (11.41) % | |||
Current Valuation | 6 M | |||
Shares Outstanding | 79.41 M | |||
Shares Owned By Insiders | 2.05 % | |||
Price To Earning | 13.82 X | |||
Price To Book | 53.47 X | |||
Price To Sales | 26.52 X | |||
Revenue | 37.73 K | |||
Gross Profit | (1.15 M) | |||
EBITDA | (3.54 M) | |||
Net Income | (2.96 M) | |||
Cash And Equivalents | 764.97 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 401.76 K | |||
Debt To Equity | 0.31 % | |||
Current Ratio | 0.38 X | |||
Book Value Per Share | (0.03) X | |||
Cash Flow From Operations | (3.64 M) | |||
Earnings Per Share | (0.03) X | |||
Target Price | 0.58 | |||
Number Of Employees | 23 | |||
Beta | 0.39 | |||
Market Capitalization | 2.13 M | |||
Total Asset | 2.27 M | |||
Retained Earnings | (18.69 M) | |||
Working Capital | 437 K | |||
Current Asset | 874 K | |||
Current Liabilities | 437 K | |||
Z Score | -11.5 | |||
Net Asset | 2.27 M |
About BiOasis Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze biOasis Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiOasis Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of biOasis Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in BiOasis Pink Sheet
BiOasis Technologies financial ratios help investors to determine whether BiOasis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BiOasis with respect to the benefits of owning BiOasis Technologies security.